72
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD

, , , , &
Pages 1683-1690 | Published online: 24 May 2018

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)From the Global Strategy for the Diagnosis, Management and Prevention of COPD2011 Available from: http://www.goldcopd.org/Accessed December 11, 2012 Ref Type: Internet Communication
  • VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
  • CelliBDecramerMKestenSUPLIFT Study InvestigatorsMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
  • CalverleyPMAndersonJACelliBTORCH InvestigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • MorjariaJBRigbyAMoriceAHInhaled corticosteroid use and the risk of pneumonia and COPD exacerbations in the UPLIFT studyLung2017195328128828255905
  • CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
  • FinneyLBerryMSinganayagamAElkinSLJohnstonSLMalliaPInhaled corticosteroids and pneumonia in chronic obstructive pulmonary diseaseLancet Respir Med201421191993225240963
  • BourbeauJAaronSDBarnesNCDavisKJLacasseYNadeauGEvaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SARespir Med2017123949728137503
  • WilkieMFinchSSchembriSInhaled corticosteroids for chronic obstructive pulmonary disease-the shifting treatment paradigmCOPD201512558259025774769
  • MagnussenHDisseBRodriguez-RoisinRWISDOM InvestigatorsWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
  • IsmailaACorriveauDVaillancourtJImpact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patientsCurr Med Res Opin20143071427143624666181
  • Koehorst-ter HuurneKMovigKvan der ValkPvan der PalenJBrusse-KeizerMDifferences in adherence to common inhaled medications in COPDCOPD201512664364825775100
  • Brusse-KeizerMZuur-TelgenMvan der PalenJAdrenomedullin optimises mortality prediction in COPD patientsRespir Med2015109673474225937049
  • Koehorst-ter HuurneKKortSvan der PalenJQuality of life and adherence to inhaled corticosteroids and tiotropium in COPD are relatedInt J Chron Obstruct Pulmon Dis2016111679168827555758
  • QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
  • MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
  • CecereLMSlatoreCGUmanJEAdherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)COPD20129325125822497533
  • KrigsmanKMoenJNilssonJLRingLRefill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year periodJ Clin Pharm Ther200732660361118021338
  • van GrunsvenPMvan SchayckCPvan DeuverenMvan HerwaardenCLAkkermansRPvan WeelCCompliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the detection, intervention, and monitoring program of COPD and asthma (DIMCA) studyJ Asthma200037322523410831147
  • SikkaRXiaFAubertREEstimating medication persistency using administrative claims dataAm J Manag Care200511744945716044982
  • LimWSvan der EerdenMMLaingRDefining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax200358537738212728155
  • StrickerBHStijnenTAnalysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studiesEur J Epidemiol201025424525120358262
  • ThomasLReyesEMTutorial: survival estimation for cox regression models with time-varying coefficients using SAS and RJ Stat Softw2014611
  • R Core TeamR: A Language and Environment for Statistical ComputingVienna, AustriaR Foundation for Statistical Computing2017 Available from: https://www.R-project.org/Accessed December 11, 2017 Ref Type: Internet Communication
  • ErnstPGonzalezAVBrassardPSuissaSInhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumoniaAm J Respir Crit Care Med2007176216216617400730
  • Koehorst-ter HuurneKMovigKvan der ValkPvan der PalenJBrusse-KeizerMThe influence of type of inhalation device on adherence of COPD patients to inhaled medicationExpert Opin Drug Deliv2015134469475
  • SimmonsMSNidesMARandCSWiseRATashkinDPUnpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trialChest2000118229029510936115
  • HauptDKrigsmanKNilssonJLMedication persistence among patients with asthma/COPD drugsPharm World Sci200830550951418247154
  • ChooPWRandCSInuiTSValidation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapyMed Care199937984685710493464